# A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers

> **NCT01087801** · PHASE3 · COMPLETED · sponsor: **ChiRhoClin, Inc.** · enrollment: 64 (actual)

## Conditions studied

- Pancreatic Disease

## Interventions

- **DRUG:** ChiRhoStim
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01087801
- **Lead sponsor:** ChiRhoClin, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2011-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01087801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01087801, "A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01087801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*